Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10F
NM
-
Nutlin 3a
MDM2
MDM2
7486.066
uM
30.82790
51.28480
-0.2762 -0.9996 2.1580 0.1174
0.9652
1.0443
MCF 10F
NM
-
Nutlin 3a
MDM2
MDM2
7487.066
uM
1.54450
2.52030
-0.0370 -0.1622 0.5736 0.3237
0.9698
1.5845
MCF 10F
NM
-
Olomoucine II
CDK1
CDK
12254.147
uM
8.6670
11.25160
-0.7461 -0.7463 3.4996 0.3007
0.9972
1.4316
MCF 10F
NM
-
Omipalisib
PI3K
PI3K
7486.087
uM
0.00232
0.00779
-0.8112 -0.6266 0.6698 1.0335
0.9769
1.1994
MCF 10F
NM
-
Oxaliplatin
DNA cross-linker
DNA cross-linker
9566.011
uM
9.96330
55.66130
-0.8028 -1.0000 0.6386 0.4382
0.9651
2.3358
MCF 10F
NM
-
Oxamflatin
HDAC
HDAC
12254.147
uM
3.72480
5.77440
-0.8841 -0.8888 2.3301 0.3318
0.9976
1.4316
MCF 10F
NM
-
PD 98059
MEK
MAPK
12254.152
uM
inf
inf
0.9135 0.9135 0.0000 0.0088
-0.0224
1.8382
MCF 10F
NM
-
PD173074
FGFR1/3
RTK
7486.1
uM
8.64950
10.98790
-0.6368 -0.6401 3.4444 0.2249
0.9969
1.0281
MCF 10F
NM
-
PD184352
MEK
MAPK
12254.155
uM
inf
inf
0.9696 0.9696 0.0000 0.0271
-0.1748
1.8150
MCF 10F
NM
-
PD184352
MEK
MAPK
12254.155
uM
inf
inf
0.9696 0.9696 0.0000 0.0271
-0.1748
1.8150
MCF 10F
NM
-
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7486.095
uM
inf
0.06460
0.5367 0.5903 2.5181 0.3337
0.9222
0.9448
MCF 10F
NM
-
Pertuzumab
7487.102
mg/ml
inf
124.94960
0.6533 -0.1750 0.2135 0.1284
0.7894
1.5273
MCF 10F
NM
-
PS-1145
IKK
NFKB
7486.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0198
-0.3050
1.1517
MCF 10F
NM
-
Purvalanol A
CDK1
CDK
7487.067
uM
15.83450
19.10550
-0.3555 -0.3584 2.8777 0.2502
0.9932
1.3523
MCF 10F
NM
-
Ribavirin
15393.211
uM
inf
inf
0.8354 0.8354 0.0000 0.0133
0.5287
1.6449
MCF 10F
NM
-
SB-3CT
MMP2/9
MMP
12254.144
uM
inf
90.76240
0.7601 0.5395 0.6974 0.0329
0.880
1.8842
MCF 10F
NM
-
Selumetinib
MEK
MAPK
12254.155
uM
3.47030
1.42990
0.2918 0.2685 0.8687 0.1974
0.9911
1.8150
MCF 10F
NM
-
Sigma A6730
AKT
AKT
12254.165
uM
5.30860
13.62360
-0.8736 -1.0000 1.1657 0.3086
0.9783
1.6980
MCF 10F
NM
-
Sirolimus
MTOR
MTOR
7488.068
uM
inf
0.00504
0.4498 0.5302 1.0402 0.3713
0.9434
1.3560
MCF 10F
NM
-
Sirolimus
MTOR
MTOR
7487.068
uM
0.03924
0.00853
0.2145 0.2858 0.5554 0.5279
0.9462
1.5003
MCF 10F
NM
-
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7487.084
uM
31.64230
39.28480
-0.9804 -0.9749 5.0000 0.4724
0.9984
1.3396
MCF 10F
NM
-
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7487.067
uM
3.76440
6.08440
-0.9938 -0.9215 2.1762 0.4657
0.9962
1.3523
MCF 10F
NM
-
Taxol
TUBB
TUBB
9566.002
uM
0.00946
0.00932
-0.0125 0.0126 1.6921 0.6239
0.9970
2.0986
MCF 10F
NM
-
TCS 2312
CHK1
CHK
12254.152
uM
2.26720
3.19210
-0.6299 -0.6350 2.3960 0.2935
0.9981
1.8382
MCF 10F
NM
-
TCS PIM-1 1
Pim kinase
PIM
12254.135
uM
inf
32.85480
0.5969 0.5482 1.5057 0.0433
0.9505
1.6637